CBL INTERNATIONAL LTD (BANL)

KYG1991X1097 - Common Stock

1.15  +0.06 (+5.5%)

Fundamental Rating

3

Taking everything into account, BANL scores 3 out of 10 in our fundamental rating. BANL was compared to 209 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for BANL as it has an excellent financial health rating, but there are worries on the profitability. BANL is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year BANL has reported negative net income.
BANL had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -0.58%, BANL is not doing good in the industry: 77.45% of the companies in the same industry are doing better.
BANL's Return On Equity of -1.66% is on the low side compared to the rest of the industry. BANL is outperformed by 74.51% of its industry peers.
BANL's Return On Invested Capital of 0.88% is on the low side compared to the rest of the industry. BANL is outperformed by 80.39% of its industry peers.
BANL had an Average Return On Invested Capital over the past 3 years of 25.33%. This is below the industry average of 28.77%.
The last Return On Invested Capital (0.88%) for BANL is well below the 3 year average (25.33%), which needs to be investigated, but indicates that BANL had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.58%
ROE -1.66%
ROIC 0.88%
ROA(3y)9.97%
ROA(5y)N/A
ROE(3y)25.92%
ROE(5y)N/A
ROIC(3y)25.33%
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of BANL has declined.
The Operating Margin of BANL (0.04%) is worse than 83.33% of its industry peers.
In the last couple of years the Operating Margin of BANL has declined.
Looking at the Gross Margin, with a value of 1.39%, BANL is doing worse than 82.84% of the companies in the same industry.
BANL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.04%
PM (TTM) N/A
GM 1.39%
OM growth 3Y-35.95%
OM growth 5YN/A
PM growth 3Y-40.45%
PM growth 5YN/A
GM growth 3Y-14.49%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BANL is creating value.
Compared to 1 year ago, BANL has more shares outstanding
There is no outstanding debt for BANL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BANL has an Altman-Z score of 11.50. This indicates that BANL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 11.50, BANL belongs to the best of the industry, outperforming 94.61% of the companies in the same industry.
BANL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.5
ROIC/WACC0.09
WACC9.43%

2.3 Liquidity

A Current Ratio of 1.51 indicates that BANL should not have too much problems paying its short term obligations.
BANL's Current ratio of 1.51 is fine compared to the rest of the industry. BANL outperforms 60.78% of its industry peers.
BANL has a Quick Ratio of 1.51. This is a normal value and indicates that BANL is financially healthy and should not expect problems in meeting its short term obligations.
BANL has a Quick ratio of 1.51. This is in the better half of the industry: BANL outperforms 67.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51

3

3. Growth

3.1 Past

BANL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -107.19%.
The earnings per share for BANL have been decreasing by -27.58% on average. This is quite bad
The Revenue has grown by 8.90% in the past year. This is quite good.
The Revenue has been growing by 22.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-107.19%
EPS 3Y-27.58%
EPS 5YN/A
EPS Q2Q%-232.99%
Revenue 1Y (TTM)8.9%
Revenue growth 3Y22.99%
Revenue growth 5YN/A
Sales Q2Q%44.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

BANL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BANL indicates a slightly more expensive valuation: BANL is more expensive than 79.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.32

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BANL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBL INTERNATIONAL LTD

NASDAQ:BANL (1/15/2025, 3:48:52 PM)

1.15

+0.06 (+5.5%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap31.62M
AnalystsN/A
Price TargetN/A
Short Float %0.34%
Short Ratio1.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA 38.32
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS25.93
BVpS0.86
TBVpS0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -1.66%
ROCE 1.09%
ROIC 0.88%
ROICexc 1.49%
ROICexgc 1.49%
OM 0.04%
PM (TTM) N/A
GM 1.39%
FCFM N/A
ROA(3y)9.97%
ROA(5y)N/A
ROE(3y)25.92%
ROE(5y)N/A
ROIC(3y)25.33%
ROIC(5y)N/A
ROICexc(3y)40.56%
ROICexc(5y)N/A
ROICexgc(3y)40.56%
ROICexgc(5y)N/A
ROCE(3y)31.4%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-35.95%
OM growth 5YN/A
PM growth 3Y-40.45%
PM growth 5YN/A
GM growth 3Y-14.49%
GM growth 5YN/A
F-Score2
Asset Turnover10.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 93.33%
Cap/Sales 0.04%
Interest Coverage 0.64
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 11.5
F-Score2
WACC9.43%
ROIC/WACC0.09
Cap/Depr(3y)299.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-107.19%
EPS 3Y-27.58%
EPS 5YN/A
EPS Q2Q%-232.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.9%
Revenue growth 3Y22.99%
Revenue growth 5YN/A
Sales Q2Q%44.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-95.84%
EBIT growth 3Y-21.23%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7318.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2553.05%
OCF growth 3YN/A
OCF growth 5YN/A